Previous studies have also reported high expression of PTTG3P in breast cancer and it has been found that PTTG3P expression is inversely correlated with estrogen receptor (ER) and progesterone receptor (PR) status, and high expression of PTTG3P is associated with poor prognosis of breast cancer [26]. The gene discussed is ESR1; the disease is breast carcinoma.